Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
Krebs von den Lungen-6 (KL-6) levels measured at baseline have been reported as a circulating biomarker useful for the detection, evaluation of severity and assessment of risk of the progression of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). In this retrospective study...
Guardado en:
Autores principales: | Yuichiro Shirai, Ryosuke Fukue, Yuko Kaneko, Masataka Kuwana |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49ce8a3fa3854df4b53b71ba526d6016 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Variation of usual interstitial pneumonia using HRCT in Scleroderma Patients
por: Vally Wulani, et al.
Publicado: (2022) -
Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review
por: Francesca Rosamilia, et al.
Publicado: (2021) -
Multi-Method Approach in the Assessment of Alexithymia in Patients With Scleroderma: Use of Two Different Tools
por: Anna Dattolo, et al.
Publicado: (2021) -
Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
por: Fischer A, et al.
Publicado: (2019) -
Clinical and Histopathological Features of Scleroderma-like Disorders: An Update
por: Rosario Foti, et al.
Publicado: (2021)